SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-20-004474
Filing Date
2020-12-29
Accepted
2020-12-29 16:33:30
Documents
52
Period of Report
2020-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT mosaic_10q-113020.htm 10-Q 607874
2 OFFER LETTER - STEVEN KING mosaic_ex1003.htm EX-10.3 19592
3 OFFER LETTER - PAUL LYTLE mosaic_ex1004.htm EX-10.4 19907
4 CERTIFICATION mosaic_ex3101.htm EX-31.1 8485
5 CERTIFICATION mosaic_ex3102.htm EX-31.2 8403
6 CERTIFICATION mosaic_ex3201.htm EX-32.1 4982
7 CERTIFICATION mosaic_ex3202.htm EX-32.2 5104
8 GRAPHIC image_002.jpg GRAPHIC 804
9 GRAPHIC image_001.jpg GRAPHIC 5203
  Complete submission text file 0001683168-20-004474.txt   2365462

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE ptsc-20201130.xml EX-101.INS 319703
11 XBRL SCHEMA FILE ptsc-20201130.xsd EX-101.SCH 23661
12 XBRL CALCULATION FILE ptsc-20201130_cal.xml EX-101.CAL 38744
13 XBRL DEFINITION FILE ptsc-20201130_def.xml EX-101.DEF 98366
14 XBRL LABEL FILE ptsc-20201130_lab.xml EX-101.LAB 162357
15 XBRL PRESENTATION FILE ptsc-20201130_pre.xml EX-101.PRE 142404
Mailing Address 19881 BROOKHURST STREET, C-245 HUNTINGTON BEACH CA 92646
Business Address 19881 BROOKHURST STREET, C-245 HUNTINGTON BEACH CA 92646 657-208-0890
Mosaic ImmunoEngineering Inc. (Filer) CIK: 0000836564 (see all company filings)

IRS No.: 841070278 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-22182 | Film No.: 201422846
SIC: 2836 Biological Products, (No Diagnostic Substances)